|
US3342824A
(en)
*
|
1964-12-07 |
1967-09-19 |
Lilly Co Eli |
Normorphines
|
|
GB1123768A
(en)
*
|
1966-07-29 |
1968-08-14 |
Smith Kline French Lab |
New thebaine and oripavine derivatives and processes for preparing the same
|
|
US3466277A
(en)
*
|
1966-12-13 |
1969-09-09 |
Boehringer Sohn Ingelheim |
N-allylic cyclohexyl lower alkyl normorphines
|
|
US3905981A
(en)
*
|
1973-10-12 |
1975-09-16 |
Research Corp |
N-dealkylation of tertiary amines
|
|
NO802139L
(no)
*
|
1979-08-09 |
1981-02-10 |
Mallinckrodt Inc |
Utgangsforbindelser for fremstilling av morfinderivater, samt fremgangsmaate til fremstilling av utgangsforbindelsene
|
|
US4613668A
(en)
*
|
1983-12-22 |
1986-09-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Short total synthesis or morphinan compounds which uses cyclization of a cycloalkylcarbonyl compound selected from cyclopropylcarbonyl and cyclobutylcarbonyl
|
|
US4722928A
(en)
*
|
1985-12-02 |
1988-02-02 |
E. I. Du Pont De Nemours And Company |
N-oxide prodrug derivatives of 3-hydroxy morphinans and partial morphinans having improved oral bioavailability, pharmaceutical compositions, and processes
|
|
US4990617A
(en)
*
|
1985-12-02 |
1991-02-05 |
E. I. Du Pont De Nemours And Company |
N-oxide prodrug derivatives of 3-hydroxy morphinans and partial morphinans and derivatives
|
|
US5668285A
(en)
*
|
1986-10-31 |
1997-09-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Total synthesis of northebaine, normophine, noroxymorphone enantiomers and derivatives via N-Nor intermediates
|
|
WO1991005768A1
(en)
*
|
1989-10-16 |
1991-05-02 |
The United States Of America, Represented By The Secretary, United States Department Of Commerce |
Total synthesis of northebaine, normorphine, noroxymorphone enantiomers and derivatives via n-nor intermediates
|
|
US5028612A
(en)
*
|
1990-03-22 |
1991-07-02 |
Hillel Glover |
Method for treating emotional numbness
|
|
ATE454169T1
(de)
*
|
2003-03-13 |
2010-01-15 |
Controlled Chemicals Inc |
Oxycodon- konjugate mit niedrigerem missbrauch- potential und ausgedehnter tätigkeitsdauer
|
|
EP1782834A3
(en)
*
|
2003-03-13 |
2007-08-01 |
Controlled Chemicals, Inc. |
Oxycodone conjugates with lower abuse potential and extended duration of action
|
|
ATE493417T1
(de)
*
|
2005-06-16 |
2011-01-15 |
Mallinckrodt Inc |
Synthetische route zu 14-hydroxylopiaten über 1- halogenthebain oder analoga
|
|
WO2008064351A2
(en)
*
|
2006-11-22 |
2008-05-29 |
Progenics Pharmaceuticals, Inc. |
(r)-n-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs
|
|
JP2010522189A
(ja)
*
|
2007-03-23 |
2010-07-01 |
マリンクロッド・インコーポレイテッド |
オリパビンからのオキシモルホンの改善された調製
|
|
DK2146961T3
(da)
|
2007-04-12 |
2014-04-28 |
Ivax Int Gmbh |
N-oxid- og/eller di-N-oxidderivater af dopaminreceptorstabilisatorer/modulatorer udvisende forbedrede cardiovaskulære bivirkningsprofiler
|
|
MX2009010931A
(es)
*
|
2007-04-16 |
2009-10-29 |
Mallinckrodt Inc |
Reduccion novedosa de opiaceos utilizando la reaccion de transferencia catalitica de hidrogeno.
|
|
EP2222642B1
(en)
*
|
2007-12-17 |
2014-02-12 |
Mallinckrodt LLC |
Process and compounds for the production of (+) opiates
|
|
WO2009078990A1
(en)
|
2007-12-17 |
2009-06-25 |
Mallinckrodt Inc. |
N-demethylation of n-methyl morphinans
|
|
AU2009300379B2
(en)
*
|
2008-09-30 |
2015-04-02 |
SpecGx LLC |
Processes for the alkylation of secondary amine groups of morphinan derivatives
|
|
WO2011008636A1
(en)
*
|
2009-07-15 |
2011-01-20 |
Mallinckrodt Inc. |
3-oxy-hydromorphone derivatives
|